BIOMAT Database Logo BIOMAT Database Logo

[Clinical significance of fibrinogen test in myocardial infarction and stenocardia]. 1958

V N KOZLOVA, and R I SANDLER

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003029 Coagulants Agents that cause clotting. Coagulant
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias

Related Publications

V N KOZLOVA, and R I SANDLER
[Post-infarction stenocardia (clinical and prognostic significance)].
January 1991, Kardiologiia,
V N KOZLOVA, and R I SANDLER
[Stenocardia and myocardial infarction].
May 1951, Fel'dsher i akusherka,
V N KOZLOVA, and R I SANDLER
[Prothrombin and fibrinogen levels in myocardial infarct and stenocardia].
January 1956, Terapevticheskii arkhiv,
V N KOZLOVA, and R I SANDLER
[Subpleural nerve block in stenocardia and myocardial infarction].
January 1989, Sovetskaia meditsina,
V N KOZLOVA, and R I SANDLER
[Characteristics and significance of cardiodynamic disorders in patients with stenocardia and a history of myocardial infarction].
March 1983, Kardiologiia,
V N KOZLOVA, and R I SANDLER
[Therapeutic effect of prostacyclins in stenocardia and myocardial infarction].
October 1988, Klinicheskaia meditsina,
V N KOZLOVA, and R I SANDLER
[Application of various anticoagulants in myocardial infarction and in stenocardia].
May 1954, Klinicheskaia meditsina,
V N KOZLOVA, and R I SANDLER
[Significance of the nitroblue-tetrazolium test in myocardial infarction].
October 1979, Arquivos brasileiros de cardiologia,
V N KOZLOVA, and R I SANDLER
[Use of isosorbide dinitrate (isoket) in stenocardia and myocardial infarction].
August 1985, Klinicheskaia meditsina,
V N KOZLOVA, and R I SANDLER
Blood fibrinogen in myocardial infarction.
November 1948, Archives of internal medicine (Chicago, Ill. : 1908),
Copied contents to your clipboard!